文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症儿科与产科急症

危重患儿严格血糖控制

Tight Glycemic Control in Critically Ill Children.
PubMed 文献 · N Engl J Med · 2017-01-24
一句话结论危重高血糖患儿(非心脏术后)目标血糖80–110 mg/dL较150–180 mg/dL不改善无ICU天数,且医疗相关感染与严重低血糖更多。

这项35中心随机试验纳入确诊高血糖的危重患儿(排除心脏术后),比较目标血糖80–110 mg/dL(4.4–6.1 mmol/L,低目标组)与150–180 mg/dL(8.3–10.0 mmol/L,高目标组),以持续血糖监测和明确的胰岛素调整方法指导临床医生。因获益可能性低且存在可能伤害的证据,试验被数据与安全监察委员会建议提前终止。713例中低目标组360例、高目标组353例,意向性分析显示第28天无ICU天数中位数两组无显著差异(19.4天[IQR 0–24.2] vs 19.4天[IQR 6.7–23.9],P=0.58);符合方案分析中低目标组时间加权平均血糖显著更低(109 mg/dL[IQR 102–118] vs 123 mg/dL[IQR 108–142],P<0.001),但医疗相关感染(3.4% vs 1.1%,P=0.04)与严重低血糖(血糖<40 mg/dL,5.2% vs 2.0%,P=0.03)更高,死亡率、器官功能障碍严重程度与无呼吸机天数无显著差异。

要点

  • 危重高血糖患儿(排除心脏术后)目标血糖80–110 mg/dL较150–180 mg/dL,第28天无ICU天数中位数无显著差异(19.4天 vs 19.4天,P=0.58)。
  • 低目标组医疗相关感染更多(12/349例[3.4%] vs 4/349例[1.1%],P=0.04)。
  • 低目标组严重低血糖(血糖<40 mg/dL[2.2 mmol/L])更多(18例[5.2%] vs 7例[2.0%],P=0.03)。
  • 试验因获益可能性低且存在可能伤害的证据被数据与安全监察委员会建议提前终止。
  • 死亡率、器官功能障碍严重程度与无呼吸机天数两组无显著差异。

适用人群与场景

  • 危重患儿,确诊高血糖,排除心脏手术后患者,纳入35中心随机试验。

诊断标准与关键阈值

  • 低目标组血糖范围80–110 mg/dL(4.4–6.1 mmol/L),高目标组150–180 mg/dL(8.3–10.0 mmol/L)。
  • 严重低血糖定义为血糖低于40 mg/dL(2.2 mmol/L)。

处置流程与药物剂量

  • 以持续血糖监测和明确的胰岛素调整方法指导临床医生进行血糖控制。

研究设计与关键结果

  • 35中心随机试验,713例危重高血糖患儿(排除心脏术后),低目标组360例、高目标组353例;因获益可能性低且存在可能伤害的证据提前终止。
  • 主要终点第28天无ICU天数中位数低目标组19.4天(IQR 0–24.2)vs 高目标组19.4天(IQR 6.7–23.9),无显著差异(P=0.58)。
  • 符合方案分析时间加权平均血糖低目标组109 mg/dL(IQR 102–118;6.1 mmol/L[IQR 5.7–6.6])vs 高目标组123 mg/dL(IQR 108–142;6.8 mmol/L[IQR 6.0–7.9]),低目标组显著更低(P<0.001)。
  • 医疗相关感染低目标组12/349例(3.4%)vs 高目标组4/349例(1.1%),P=0.04。
  • 严重低血糖(血糖<40 mg/dL[2.2 mmol/L])低目标组18例(5.2%)vs 高目标组7例(2.0%),P=0.03。
  • 死亡率、器官功能障碍严重程度、无呼吸机天数两组无显著差异。

证据类型、等级与局限

  • 随机对照试验(HALF-PINT,ClinicalTrials.gov NCT01565941),由美国国家心肺血液研究所等资助;因获益可能性低且存在可能伤害的证据提前终止。

对床旁实践的改变

  • 作者结论:危重高血糖患儿目标血糖80–110 mg/dL较150–180 mg/dL无获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In multicenter studies, tight glycemic control targeting a normal blood glucose level has not been shown to improve outcomes in critically ill adults or children after cardiac surgery. Studies involving critically ill children who have not undergone cardiac surgery are lacking.

METHODS: In a 35-center trial, we randomly assigned critically ill children with confirmed hyperglycemia (excluding patients who had undergone cardiac surgery) to one of two ranges of glycemic control: 80 to 110 mg per deciliter (4.4 to 6.1 mmol per liter; lower-target group) or 150 to 180 mg per deciliter (8.3 to 10.0 mmol per liter; higher-target group). Clinicians were guided by continuous glucose monitoring and explicit methods for insulin adjustment. The primary outcome was the number of intensive care unit (ICU)-free days to day 28.

RESULTS: The trial was stopped early, on the recommendation of the data and safety monitoring board, owing to a low likelihood of benefit and evidence of the possibility of harm. Of 713 patients, 360 were randomly assigned to the lower-target group and 353 to the higher-target group. In the intention-to-treat analysis, the median number of ICU-free days did not differ significantly between the lower-target group and the higher-target group (19.4 days [interquartile range {IQR}, 0 to 24.2] and 19.4 days [IQR, 6.7 to 23.9], respectively; P=0.58). In per-protocol analyses, the median time-weighted average glucose level was significantly lower in the lower-target group (109 mg per deciliter [IQR, 102 to 118]; 6.1 mmol per liter [IQR, 5.7 to 6.6]) than in the higher-target group (123 mg per deciliter [IQR, 108 to 142]; 6.8 mmol per liter [IQR, 6.0 to 7.9]; P<0.001). Patients in the lower-target group also had higher rates of health care-associated infections than those in the higher-target group (12 of 349 patients [3.4%] vs. 4 of 349 [1.1%], P=0.04), as well as higher rates of severe hypoglycemia, defined as a blood glucose level below 40 mg per deciliter (2.2 mmol per liter) (18 patients [5.2%] vs. 7 [2.0%], P=0.03). No significant differences were observed in mortality, severity of organ dysfunction, or the number of ventilator-free days.

CONCLUSIONS: Critically ill children with hyperglycemia did not benefit from tight glycemic control targeted to a blood glucose level of 80 to 110 mg per deciliter, as compared with a level of 150 to 180 mg per deciliter. (Funded by the National Heart, Lung, and Blood Institute and others; HALF-PINT ClinicalTrials.gov number, NCT01565941 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Agus MS, Wypij D, Hirshberg EL, et al. Tight Glycemic Control in Critically Ill Children. N Engl J Med. 2017. PMID: 28118549. doi:10.1056/NEJMoa1612348

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。